{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T23:06:25Z","timestamp":1784934385909,"version":"3.55.0"},"reference-count":35,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T00:00:00Z","timestamp":1589846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and objectives. Venous thromboembolic events (VTEs) are among the most important complications of nephrotic syndrome (NS). We conducted a study that aimed to determine the prevalence of inherited risk factors for VTE in NS and to identify which factors are independent predictors of VTE. Materials and Methods. Thirty-six consecutive patients with primary NS that underwent percutaneous kidney biopsy between January 2017 and December 2017 were enrolled in this retrospective, observational study. VTEs were the primary outcome. Baseline demographic and biochemical data were collected from medical records, and genetic testing was done for polymorphisms of Factor V, PAI, MTHFR, and prothrombin genes. Results. The incidence of VTE was 28%, and the median time to event was 3 months (IQR: 2\u20139). The prevalence of inherited risk factors was 14% for Factor V Leiden mutation, 5.6% for prothrombin G20210A, 44.5% for PAI, and 27.8% for each of the two polymorphisms of the MTHFR gene. On multivariate analysis, the presence of at least two mutations was independently associated with the risk of VTE (HR, 8.92; 95% confidence interval, CI: 1.001 to 79.58, p = 0,05). Conclusions. These findings suggest that genetic testing for inherited thrombophilia in NS could play an important role in detecting high-risk patients that warrant prophylactic anticoagulation.<\/jats:p>","DOI":"10.3390\/medicina56050242","type":"journal-article","created":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T02:48:24Z","timestamp":1589942904000},"page":"242","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Inherited Risk Factors of Thromboembolic Events in Patients with Primary Nephrotic Syndrome"],"prefix":"10.3390","volume":"56","author":[{"given":"Gener","family":"Ismail","sequence":"first","affiliation":[{"name":"Department of Nephrology, Fundeni Clinical Institute, Bucharest 022328, Romania"},{"name":"Department of Uronephrology, \u201cCarol Davila\u201d University of Medicine and Pharmacy, Bucharest 020021, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4796-4950","authenticated-orcid":false,"given":"Bogdan","family":"Obri\u0219c\u0103","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Fundeni Clinical Institute, Bucharest 022328, Romania"},{"name":"Department of Uronephrology, \u201cCarol Davila\u201d University of Medicine and Pharmacy, Bucharest 020021, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxana","family":"Jurubi\u021b\u0103","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Fundeni Clinical Institute, Bucharest 022328, Romania"},{"name":"Department of Uronephrology, \u201cCarol Davila\u201d University of Medicine and Pharmacy, Bucharest 020021, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5590-7879","authenticated-orcid":false,"given":"Andreea","family":"Andronesi","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Fundeni Clinical Institute, Bucharest 022328, Romania"},{"name":"Department of Uronephrology, \u201cCarol Davila\u201d University of Medicine and Pharmacy, Bucharest 020021, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3574-4635","authenticated-orcid":false,"given":"Bogdan","family":"Sorohan","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Fundeni Clinical Institute, Bucharest 022328, Romania"},{"name":"Department of Uronephrology, \u201cCarol Davila\u201d University of Medicine and Pharmacy, Bucharest 020021, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihai","family":"H\u00e2rza","sequence":"additional","affiliation":[{"name":"Department of Uronephrology, \u201cCarol Davila\u201d University of Medicine and Pharmacy, Bucharest 020021, Romania"},{"name":"Center of Uronephrology and Renal Transplantation, Fundeni Clinical Institute, Bucharest 022328, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,5,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2215\/CJN.10131011","article-title":"Epidemiology and pathophysiology of nephrotic syndrome-associated thromboembolic disease","volume":"7","author":"Kerlin","year":"2012","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1681\/ASN.2006111300","article-title":"Prophylactic anticoagulation in nephrotic syndrome: A clinical conundrum","volume":"18","author":"Glassock","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.thromres.2005.03.030","article-title":"Thromboembolic complications in the nephrotic syndrome: Pathophysiology and clinical management","volume":"118","author":"Singhal","year":"2006","journal-title":"Thromb. Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000188355","article-title":"Prevention of thrombotic complications of the nephrotic syndrome by low molecular weight heparin enoxaparin","volume":"69","author":"Rostoker","year":"1995","journal-title":"Nephron"},{"key":"ref_5","unstructured":"KDIGO Working Group (2012). KDIGO clinical practice guideline for glomerulonephritis. Kidney Int. Suppl., 2, 1\u2013274."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/01.GIM.0000067987.77803.D0","article-title":"Role of the geneticist in testing and counseling for inherited thrombophilia","volume":"5","author":"Reich","year":"2003","journal-title":"Genet. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s11255-013-0574-0","article-title":"Risk factors for predicting venous thromboembolism in patients with nephrotic syndrome: Focus on haemostasis-related parameters","volume":"46","author":"Ismail","year":"2014","journal-title":"Int. Urol. Nephrol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/ki.2011.312","article-title":"Disease-specific risk of venous thromboembolic events is increased in idiopathic glomerulonephritis","volume":"81","author":"Barbour","year":"2012","journal-title":"Kidney Int."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Kumar, S., Chapagain, A., Nitsch, D., and Yaqoob, M.M. (2012). Proteinuria and hypoalbuminemia are risk factors for thromboembolic events in patients with idiopathic membranous nephropathy: An observational study. BMC Nephrol., 13.","DOI":"10.1186\/1471-2369-13-107"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1161\/CIRCULATIONAHA.107.716951","article-title":"High absolute risks and predictors of venous and arterial thromboembolic events in patients with nephrotic syndrome: Results from a large retrospective cohort study","volume":"117","author":"Mahmoodi","year":"2008","journal-title":"Circulation"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"311","DOI":"10.5414\/CN108055","article-title":"Methylenetetrahydrofolate reductase gene polymorphisms in patients with nephrotic syndrome","volume":"80","author":"Beyan","year":"2013","journal-title":"Clin. Nephrol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"454","DOI":"10.5414\/CN107863","article-title":"Assessment of genetic risk factors for thromboembolic complications in adults with idiopathic nephrotic syndrome","volume":"79","author":"Sahin","year":"2013","journal-title":"Clin. Nephrol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s004310050972","article-title":"Inherited risk factors for thrombophilia in children with nephrotic syndrome","volume":"157","author":"Fabri","year":"1998","journal-title":"Eur. J. Pediatr."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1093\/ndt\/12.8.1680","article-title":"The factor V Leiden mutation and risk of renal vein thrombosis in patients with nephrotic syndrome","volume":"12","author":"Irish","year":"1997","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"895","DOI":"10.7326\/0003-4819-127-10-199711150-00007","article-title":"Factor V Leiden Mutation and the Risks for Thromboembolic Disease: A Clinical Perspective","volume":"127","author":"Price","year":"1997","journal-title":"Ann. Intern. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1182\/blood-2012-01-401513","article-title":"Homocysteine and thrombosis: Guilt by association?","volume":"119","author":"Fay","year":"2012","journal-title":"Blood"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1182\/blood-2008-01-077909","article-title":"Advances in understanding pathogenic mechanisms of thrombophilic disorders","volume":"112","author":"Dahlback","year":"2008","journal-title":"Blood"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"478","DOI":"10.2215\/CJN.07190713","article-title":"Retrospective analysis of a novel regimen for the prevention of venous thromboembolism in nephrotic syndrome","volume":"9","author":"Ziaj","year":"2014","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/ki.1985.149","article-title":"Hypercoagulability, renal vein thrombosis, and other thrombotic complications of nephrotic syndrome: Editorial review","volume":"28","author":"Llach","year":"1985","journal-title":"Kidney Int."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000187205","article-title":"Membranous nephropathy and thromboembolism: Is prophylactic anticoagulation warranted?","volume":"63","year":"1993","journal-title":"Nephron"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/ki.1983.28","article-title":"Renal vein thrombosis in idiopathic membranous glomerulopathy and nephrotic syndrome: Incidence and significance","volume":"23","author":"Wagoner","year":"1983","journal-title":"Kidney Int."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1159\/000167654","article-title":"Idiopathic Nephrotic Syndrome of the Adult with Asymptomatic Thrombosis of the Renal Vein","volume":"8","year":"1988","journal-title":"Am. J. Nephrol."},{"key":"ref_23","first-page":"725","article-title":"Prophylaxis of thromboembolic events in patients with nephrotic syndrome","volume":"47","author":"Pincus","year":"2013","journal-title":"Ann. Pharm."},{"key":"ref_24","first-page":"555","article-title":"Histological diagnosis and risk of renal vein thrombosis and other thrombotic complications in primitive nephrotic syndrome","volume":"54","author":"Harza","year":"2013","journal-title":"Rom. J. Morphol. Embryol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/ajh.10192","article-title":"PAI-1 gene 4G\/5G genotype: A risk factor for thrombosis in vessels of internal organs","volume":"71","author":"Balta","year":"2002","journal-title":"Am. J. Hematol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1538-7836.2005.01141.x","article-title":"Homocysteine, MTHFR and risk of venous thrombosis: A meta-analysis of published epidemiological studies","volume":"3","author":"Lewington","year":"2005","journal-title":"J. Thromb. Haemost."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1440-1797.2009.01128.x","article-title":"Coagulation cascade and therapeutics update: Relevance to nephrology. Part 1: Overview of coagulation, thrombophilias and history of anticoagulants","volume":"14","author":"Adams","year":"2009","journal-title":"Nephrology"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1191\/1358863x02vm426ra","article-title":"Laboratory thrombophilias and venous thromboembolism","volume":"7","author":"Joffe","year":"2002","journal-title":"Vasc. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1001\/archinte.166.7.729","article-title":"Risk of Recurrent Venous Thromboembolism in Patients With Common Thrombophilia","volume":"166","author":"Ho","year":"2006","journal-title":"Arch. Intern. Med."},{"key":"ref_30","first-page":"2472","article-title":"Prothrombin G20210A in Adults With Venous Thromboembolism and in A Systematic Review","volume":"301","author":"Brotman","year":"2014","journal-title":"JAMA"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1161\/CIRCULATIONAHA.109.906347","article-title":"Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor v leiden and prothrombin G20210A","volume":"121","author":"Lijfering","year":"2010","journal-title":"Circulation"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s11239-015-1316-1","article-title":"Guidance for the evaluation and treatment of hereditary and acquired thrombophilia","volume":"41","author":"Stevens","year":"2016","journal-title":"J. Thromb. Thrombolysis"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1056\/NEJM199909093411104","article-title":"The risk of recurrent deep vein thrombosis among heterozygous carriers of both Factor V Leiden and the G20210A Prothrombin mutation","volume":"341","author":"Martinelli","year":"1999","journal-title":"N. Eng. J. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/01.mbc.0000201488.33143.09","article-title":"Risk of recurrent venous thrombosis in patients with G20210A mutation in the prothrombin gene or factor V Leiden mutation","volume":"17","author":"Alberca","year":"2006","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1161\/01.CIR.0000079162.69615.0F","article-title":"Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia","volume":"108","author":"Palareti","year":"2003","journal-title":"Circulation"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/56\/5\/242\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:30:17Z","timestamp":1760175017000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/56\/5\/242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,19]]},"references-count":35,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,5]]}},"alternative-id":["medicina56050242"],"URL":"https:\/\/doi.org\/10.3390\/medicina56050242","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,19]]}}}